logo
Farmed Production of Some Fish - and Seaweed

Farmed Production of Some Fish - and Seaweed

Asharq Al-Awsat09-06-2025
The amount of farmed seafood we consume -- as opposed to that taken wild from our waters -- is soaring every year, making aquaculture an ever-more important source for many diets, and a response to overfishing.
According to the UN's Food and Agriculture Organization, nearly 99 million tons of aquatic animals (fish, molluscs like oysters and mussels and crustaceans like prawns) were farmed around the world in 2023, five times more than three decades ago.
Since 2022, the farming of aquatic animals has been steadily overtaking fishing around the world -- but with large disparities from species to species.
Fast-growing species
The two biggest sellers on the market in 2023, carp and tilapia, mainly came from freshwater farming, while other widely-consumed fish, like herring, came just from deep sea fishing
Thierry Laugier, a researcher at Ifremer, France's national institute for ocean science and technology, told AFP that fish farmers choose species that grow quickly and with simple requirements, to be able to control the life cycle.
Sales of the most widely farmed fish in Europe, Atlantic salmon, came to 1.9 million tons in 2023, 99 percent of which were farmed.
"We know how to control the ageing or how to launch a reproduction cycle, through injecting hormones," Laugier said.
Asia main producer
Asia is by far the biggest producer of farmed fish, accounting for 92 percent of the 136 million tons -- of both animal and plant species -- produced under manmade conditions in 2023.
"For carp, it comes down to tradition, it has been farmed for thousands of years on the Asian continent," the Ifremer researcher said.
At the other end of the spectrum, sardines and herring are just fished in the oceans, mainly for profitability reasons as some fish grow very slowly.
"It takes around two years to get an adult-sized sardine," Laugier said.
He said farming of some fish has not yet been started as, "for a long time, we thought the ocean was an inexhaustible resource".
Seaweed
Little known in the West, seaweed nevertheless accounts for almost a third of world aquaculture production.
Almost exclusively from Asia, seaweed production increased by nearly 200 percent in two decades, to 38 million tons. It is mainly used in industry, in jellies, pharmaceuticals and cosmetics, the expert said.
He said seaweed also has the major advantage of absorbing not just CO2 in the oceans, but also nitrogen and certain pollutants.
"And from an ecological point of view it is better to farm macroalgae than salmon," Laugier said.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

How quantum computing and AI can accelerate and improve drug development
How quantum computing and AI can accelerate and improve drug development

Arab News

time17-07-2025

  • Arab News

How quantum computing and AI can accelerate and improve drug development

RIYADH: Using traditional discovery processes, a staggering 90 percent of drug development trials are unsuccessful. But what if there is a future in which quantum technologies could revolutionize that process to achieve unprecedented efficiency? The race to develop quantum computers has been surging worldwide. In April, IBM announced a $150 billion investment plan to strengthen US technologies and innovation over the next five years, including a push for quantum computer development. Additionally, the UK's National Quantum Technologies Programme has invested more than £1 billion in quantum technology since its establishment in 2014, with facilities such as the National Quantum Computing Centre. PASQAL in France is also a leading company in quantum research. In 2024, Saudi Aramco signed an agreement with PASQAL to deploy the first quantum computer in the Kingdom, scheduled to be up and running by the end of this year. If the promise of quantum computing holds, the pharmaceutical industry could be looking at faster, more accurate, and less costly drug discovery and development. The World Health Organization predicts that antimicrobial resistance to existing drugs will lead to 10 million human deaths by 2050. To stop the timer, the pharmaceutical industry must adopt new and innovative technologies. Artificial intelligence has already had a huge impact on the efficiency and success of clinical trials, generating new materials and computationally predicting their performance rather than relying on scientists' intuition for molecular hypotheses that then must be synthesized and tested repeatedly. Quantum computing, however, has the potential to take it one step further. It uses special units called qubits (quantum bits), which can exist in multiple states at once and can link together in unique ways, to perform computations much more efficiently than classical computers. In layman's terms, quantum computers solve complicated problems quicker while AI simplifies the problem and then solves it. Quantum computers understand the problem. AI does not. A research scientist focusing on computational catalysis with a doctoral degree in chemical engineering spoke to Arab News about the current feasibility of this tool. 'We are talking about mature technology (AI) versus very immature technology (quantum),' he said. According to the World Economic Forum, in synergy, quantum computing and AI can lead to enhanced molecular understanding. Although our expert heeds that 'we are not at the stage where we can actually do that, we can only do it on very specific problems because there are many physical limitations… you need to be able to manipulate atoms in a very precise way that we currently cannot do.' Quantum physics allows scientists to predict the behavior of electrons in molecules, producing detailed three-dimensional structural insight into new drug designs. Rather than adopting traditional laborious methods such as X-ray crystallography, quantum principles and AI provide virtual simulations. AI further accelerates this process by quickly analyzing datasets and clinical outcomes to pin down favorable drug targets and predict a compound's efficacy. A novel tool called quantum machine learning combines AI's power of data analysis and pattern recognition with quantum computing's ability to simulate complex molecular behavior throughout trillions of possibilities. This paves the way to more accurate and faster predictions in drug binding orientation, absorption, and metabolic pathways. QML makes it possible to sift through vast chemical spaces holding trillions of potential drug candidates in weeks or days in contrast to the years that classical computers would need. With the integration of quantum computing and AI, compound screening traditionally executed 'in vitro,' meaning outside of a living organism, can be done 'in silico' instead, meaning carried out in virtual simulations. A new quantum-AI model developed by Qubit Pharmaceuticals with Sorbonne University and announced in May of this year called FeNNix-Bio1, reportedly leverages unprecedented computational power and very accurate molecular databases. Employing the principles of quantum mechanics (such as superposition and entanglement), quantum computers can model molecular and atomic behavior with great accuracy and speed. This is critical to understanding relevant properties such as molecular stability, binding affinity, and how drugs could interact with target proteins in real-world conditions. Structural optimization and docking — determining how a drug candidate fits into a biological target, can be simplified using QML and quantum-powered algorithms. These algorithms rapidly evaluate orientations of molecules against target structures to identify optimal configurations, and which molecules will bind most effectively. This enhances drug absorption and metabolic stability. Quantum computing and AI models are then able to streamline the preclinical phase, delivering only the most promising compounds to laboratory validation, significantly reducing tedious lab work and enabling researchers to conduct faster and cheaper work. And with more accurate early-stage predictions, overall success of clinical trials is boosted, lab to market time is reduced, and the possibility of delivering targeted treatments for unmet patient needs is increased. 'You do patient trials to reduce the risk of anything going wrong with the patient, imagine if you are able to accurately predict how the drug will affect people without doing a trial. This will create a leap in how we produce drugs and how we can commercialize drugs,' our expert said. Meeting specific patient needs based on their biological profiles rather than producing drugs for a wide demographic can drastically change our healthcare systems and how we consume products. Patients will be able to get a drug for diseases such as Alzheimer's, diabetes, cancer, and more without having to wait ten years for a trial to decide their fate. You can also anticipate what conditions or illnesses people are at high risk of developing later in life and treat them early on, such as joint pain and hair loss. It comes down to significant time reduction and improved chances of success. 'A quantum computer can significantly increase my accuracy. My chances of success are very dependent on my prediction of the performance. 'The quantum computer can make more accurate calculations that can make my predictions of the performance much more accurate. By doing that, my chances of success will be higher. 'Another way is that a quantum computer will be much faster in performing tasks, generating structures and predicting their performance than AI, and by that I will reduce my time further.' Although we are still a long way from achieving this, the functionality of quantum computing and AI theorizes that personalized medicine and treatments for patients is possible. 'If (specific patient information) becomes accessible to those companies… then they match that information to their database, hypothetically speaking it is possible.' Although this all sounds like the realms of sci-fi, there have been significant strides in this area of quantum research. Pfizer and its partner XtalPi, a US-China pharmaceutical tech company, reportedly used quantum-inspired algorithms and AI cloud computing to reduce 3D structure prediction time of new molecules from months to days, enabling rapid assessment of candidate molecules and their drug-likeness. Additionally, it is said that Qubit Pharmaceuticals' FeNNix-Bio1 quantum AI model could be used for QML applications such predicting toxicity, side effects, and drug metabolism with greater speed and accuracy. Taking it into perspective, our expert said: 'Three years ago, no one would have thought we would have a large language model that can perform as well as ChatGPT does today, it came out of left field. A breakthrough could happen.' However, WEF warns that before this technology can become the new commercial norm, certain guardrails need to be put in place to ensure the safe, effective, and responsible use of this novel tool. Data integrity and avoiding bias, ethical and regulatory oversight, workforce readiness training, and a shared vision for applying best practices all must be upheld industry wide.

What We Are Reading Today: ‘In The Brain, In Theory'
What We Are Reading Today: ‘In The Brain, In Theory'

Arab News

time15-07-2025

  • Arab News

What We Are Reading Today: ‘In The Brain, In Theory'

Author: ROMAIN BRETTE 'In The Brain, In Theory,' Romain Brette argues that the brain is not a 'biological computer' because living organisms are not engineered. Engineering is the use of knowledge to solve technical problems, to build an artifact with a plan. Brette reviews the main theoretical frameworks for thinking about the brain, including computation, neural representations, information, and prediction, and finds them poorly suited to the study of biological cognition. He proposes understanding the brain as a self-organized, developing community of living entities rather than an optimized assembly of machine components.

UN Sand & Dust Storms Meeting: Saudi Arabia's Efforts Gain Recognition
UN Sand & Dust Storms Meeting: Saudi Arabia's Efforts Gain Recognition

Leaders

time12-07-2025

  • Leaders

UN Sand & Dust Storms Meeting: Saudi Arabia's Efforts Gain Recognition

Saudi Arabia has gained global recognition for its international efforts in bolstering early-warning systems for sand and dust storms. The High-level Meeting on Sand and Dust Storms, which took place at the UN headquarters in New York, also praised the Kingdom's role in spearheading regional cooperation. The meeting convened in the context of the International Day of Combating Sand and Dust Storms, marked on July 12 each year. International Recognition The high-level meeting hailed the Kingdom's global initiative to boost early-warning systems for sand and dust storms, according to the Saudi Press Agency (SPA). It also highlighted Saudi Arabia's cooperation with regional centers affiliated with the World Meteorological Organization (WMO) to strengthen dust combat, pointing to the Kingdom's $10 million commitment over 5 years to enhance the capabilities of the vulnerable countries. Unwavering Commitment On its part, Saudi Arabia underscored its firm commitment to supporting climate and environmental action, and fostering scientific and technical cooperation to tackle the impacts of sand and dust storms, on the local, regional and international levels. These initiatives come in line with the Kingdom's strategic vision and ongoing efforts to protect the environment and achieve sustainability. On this occasion, the deputy CEO of the National Center for Meteorology (NCM) and Executive Chief of the Sand and Dust Storm Regional Center, Jumaan Al-Qahtani, outlined the Kingdom's efforts to combat dust storms under Saudi Vision 2030. These efforts include the Saudi Green Initiative (SGI), the Middle East Green Initiative, and the establishment of specialized centers such as the Regional Center for Sand and Dust Storms, the Climate Change Center, the Cloud Seeding Program, and the National Center for Vegetation Cover Development. Saudi Arabia's Efforts Al-Qahtani highlighted the establishment of the Regional Center for Dust and Sand Storms in Jeddah in 2022, which marked a strategic milestone toward improving dust storms' prediction and strengthening early-warning. The Jeddah Center serves as a hub for supporting early-warning systems, data exchange, capacity building, and mitigating the health and economic impacts of storms in coordination with the WMO. Furthermore, Al-Qahtani boasted the Kingdom's scientific and research efforts, including hosting the First International Conference on Dust and Sand Storms in Riyadh in March 2024. They also include hosting regional workshops in collaboration with the WMO and ESCWA (the UN Economic and Social Commission for Western Asia), and cooperating with international centers such as WMO Barcelona Dust Regional Center. In the light of this, he announced Saudi Arabia's readiness to host the second International Conference on Sand and Dust Storms in 2026 to build on the scientific momentum and assess the progress achieved since the Riyadh declaration, in addition to discussing challenges and solutions related to dust and sand storms. Tangible Results Owing to Saudi Arabia's tireless efforts and environmental initiatives, the Kingdom has planted over 142 million trees and reclaimed more than 436,000 hectares of degraded land. It has also managed to protect 18% of its land, under the (30×30) plan endorsed by the International Union for Conservation of Nature (IUCN), in addition to launching 7 royal reserves, representing 13.5% of Saudi Arabia's total area. Moreover, Al-Qahtani emphasized the Kingdom's commitment to supporting international efforts and expanding partnerships to develop early-warning systems, protect human and the environment, and build more resilient societies in the face of climate change and dust storms. Dangers of Sand & Dust Storms Under the theme 'Sand and Dust Storms: Working Across Agendas for Resilience and Sustainability,' the high-level meeting convened at the UN headquarters on July 10 to discuss the challenges posed by sand and dust storms on affected countries. It also aimed to promote practical, coordinated actions at both regional and global levels. Moreover, the Secretary-General of the WMO, Celeste Saulo, highlighted the dangers of sand and dust storms, which 'affect more than 150 countries and impact about 330 million people worldwide.' Saulo explained that 'about 2 billion tons of dust are emitted yearly, equivalent in weight to 307 Great Pyramids of Giza,' adding that 'more than 80% of the global dust budget emanates from the North African and Middle Eastern deserts.' However, this dust has a global impact because it can travel hundreds and thousands of kilometers across continents and oceans, profoundly affecting health and quality of life, air and ground transport, agriculture and the environment, and solar energy production. Sand and dust storms are exacerbated by climate change, land degradation and unsustainable practices. They contribute to 7 million premature deaths every year, causing respiratory and cardiovascular disease, according to Assembly President, Philemon Yang. They also reduce crop yields by up to 25%, causing hunger and driving migration. Short link : Post Views: 9

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store